Trials / Active Not Recruiting
Active Not RecruitingNCT06196684
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
Early Safety and Clinical Efficacy of Mitral Allografts in Patients With Primary Tricuspid Valve Disease Scheduled for Tricuspid Valve Replacement
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Chelyabinsk Regional Clinical Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate early safety and clinical efficacy of mitral allografts in tricuspid valve replacement for primary tricuspid valve diseases.
Detailed description
Early safety (morbidity, mortality rate, freedom from any valve related complication) along with mid-term clinical efficacy ( mid-term survival, freedom from reoperation, repeat endocarditis and other valve related complication ) is going to be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Mitral allograft implantation | Tricuspid valve replacement with mitral valve allograft |
Timeline
- Start date
- 2021-09-29
- Primary completion
- 2026-09-29
- Completion
- 2026-10-30
- First posted
- 2024-01-09
- Last updated
- 2025-10-06
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT06196684. Inclusion in this directory is not an endorsement.